Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2025 Jan 7;17:17588359241295544. doi: 10.1177/17588359241295544

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2025

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — The one-way sensitivity analyses for the enfortumab vedotin plus pembrolizumab compared to the chemotherapy in the United States (a) and China (b), respectively.

AEs, adverse events; BSC, best supportive care; EV, enfortumab vedotin; EV + P, enfortumab vedotin plus pembrolizumab; ICER, incremental cost-effectiveness ratio; PD, progressive disease; PFS, progression-free survival; QALY, quality-adjusted life-year.